March 25, 2025 - 04:05

Shares in Asia exhibited a mixed performance on Tuesday, with notable declines in Chinese markets following a significant rally on Wall Street. The optimism in the U.S. was largely driven by expectations that the Trump administration might adopt a more focused strategy regarding the upcoming round of tariffs on imported goods, set to be announced next week.
In the wake of this news, U.S. futures experienced a slight dip, while oil prices remained relatively stable. Among the notable movements, Xiaomi, a prominent cell phone manufacturer, saw its shares traded in Hong Kong fall by 5.4%. Similarly, the delivery app firm Meituan faced a decline of 4.2%.
These fluctuations reflect the ongoing uncertainty in global markets as investors remain cautious ahead of new trade policies and their potential impact on the economic landscape. The mixed results highlight the delicate balance between optimism and caution as market participants navigate the evolving situation.
August 27, 2026 - 09:43
EverGen Infrastructure Reports Q2 2026 ResultsVANCOUVER - EverGen Infrastructure Corp. has released its financial results for the second quarter of 2026, covering the period ending June 30. The company, which focuses on renewable natural gas...
August 26, 2026 - 19:01
Nutanix Reports Fourth Quarter and Fiscal 2026 Financial ResultsNutanix has reported financial results for its fourth quarter and full fiscal year ending July 31, 2026, highlighting a 16 percent year-over-year increase in annual recurring revenue (ARR). The...
August 26, 2026 - 03:06
The multiplying risks of financing data centresWall Street`s biggest financial institutions are diving headfirst into the data center gold rush, but the euphoria is starting to meet a wall of caution. As the demand for artificial intelligence...
August 25, 2026 - 23:39
Akin, an Elite Global Law FirmDallas - Akin, a global law firm, recently provided legal counsel to Crestline Direct Finance, L.P. in connection with a $50 million senior secured credit facility extended to Kreg Therapeutics LLC...